Omara Dogar, Ada Keding, Rhian Gabe, Anna‐Marie Marshall et al.
BACKGROUND: Smoking cessation is important in patients with tuberculosis because it can reduce the high rates of treatment failure and mortality. We aimed to assess the effectiveness and safety of cystine as a smoking cessation aid in patients with tuberculosis in Bangladesh and Pakistan. METHODS: W...
Kamran Siddiqi, Ada Keding, Anna‐Marie Marshall, Omara Dogar et al.
Background Despite treatment, patients with tuberculosis (TB) who smoke have poorer outcomes compared with non-smokers. It is unknown, however, if quitting smoking during the 6 months of TB treatment improves TB outcomes. Methods The TB & Tobacco Trial was a double-blind, placebo-controlled rand...
Omara Dogar, Deepa Barua, Melanie Boeckmann, Helen Elsey et al.
BACKGROUND AND AIMS: Tuberculosis (TB) patients who quit smoking have much better disease outcomes than those who continue to smoke. In general populations, behavioural support combined with pharmacotherapy is the most effective strategy in helping people to quit. However, there is no evidence for t...
Anna‐Marie Marshall, Deepa Barua, Alex Mitchell, Ada Keding et al.
INTRODUCTION: Smoking has a negative impact on TB outcomes. We estimated the proportion of TB patients who smoke and are willing to quit in two high TB burden countries, Bangladesh and Pakistan. METHODS: A cross-sectional survey was conducted among TB patients to assess their eligibility and recruit...
Melanie Boeckmann, Sahil Khan Warsi, Maryam Noor, Omara Dogar et al.
Smoking worsens tuberculosis (TB) outcomes. Persons with TB who smoke can benefit from smoking cessation. We report findings of a multi-country qualitative process evaluation assessing barriers and facilitators to implementation of smoking cessation behaviour support in TB clinics in Bangladesh and ...
Naveed Ahmed, Gerardo A. Zavala, Faraz Siddiqui, Faiza Aslam et al.
There is a lack of evidence on effective treatments for depression in people with T2DM, particularly in Low and Middle-Income Countries (LMICs). This study aims to test the feasibility and acceptability of a culturally adapted Behavioural Activation (BA) intervention (DiaDeM) for people with depress...
Jinshuo Li, Steve Parrott, Ada Keding, Omara Dogar et al.
OBJECTIVES: To assess the cost-effectiveness of cytisine over and above brief behavioural support (BS) for smoking cessation among patients who are newly diagnosed with pulmonary tuberculosis (TB) in low-income and middle-income countries. DESIGN: An incremental cost-utility analysis was undertaken ...
Faraz Siddiqui, Faiza Aslam, Naveed Ahmed, Saima Afaq et al.
Abstract Background The co-occurrence of depression among individuals with type 2 diabetes is a recognised global health problem and can lead to poorer health outcomes for both conditions. Behavioural activation is an evidence-based brief, low-cost psychological therapy which can be delivered by tra...
Hannah Maria Jennings, Anum Naz, Ashraful Anas, Shaker Khan et al.
Omara Dogar, Ada Keding, Rhian Gabe, Anna‐Marie Marshall et al.